ADVANZ PHARMA Holdco Limited, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines across Europe, Canada, and Australia, has completed the purchase of the commercial rights to Testoviron® from Bayer for Europe and selected markets in Latin America, the Middle East & Africa, and Asia-Pacific..

ADVANZ PHARMA控股有限公司是一家总部位于英国的全球制药公司，专注于欧洲、加拿大和澳大利亚的专科、医院和罕见病药物。该公司已完成从拜耳购买Testoviron®在欧洲及拉美、中东和非洲以及亚太部分市场的商业权利。

Testoviron® is a long-acting injectable testosterone used to treat male hypogonadism*. Adding the brand strengthens ADVANZ PHARMA’s specialty portfolio and leverages its commercial and medical operations in Europe and global partner network.

Testoviron® 是一种长效注射用睾酮，用于治疗男性性腺功能减退症*。增加该品牌强化了ADVANZ PHARMA的专业产品组合，并利用了其在欧洲的商业和医学运营以及全球合作伙伴网络。

The transaction builds on existing agreements between ADVANZ PHARMA and Bayer. Financial terms are not being disclosed.

该交易基于ADVANZ PHARMA与拜耳之间现有的协议。财务条款未披露。

*Indications vary by market, strength, and form. For local indications please check the local approved label

*不同市场、强度和形式的适应症可能有所不同。有关本地适应症，请查看当地批准的标签。

About ADVANZ PHARMA

关于ADVANZ PHARMA

Partner of choice in specialty, hospital, and rare disease medicines

在专科、医院和罕见病药物领域的首选合作伙伴

ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing and enhancing the specialty, hospital, and rare disease medicines they depend on. Our headquarters are in London, UK. We have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia, a Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network.

ADVANZ PHARMA是一家全球性的制药公司，致力于通过提供和改进患者所依赖的专科、医院和罕见病药物来改善患者的生活。我们总部位于英国伦敦，在全球90多个国家拥有商业销售业务，并在20多个国家拥有直接商业存在，包括欧洲、美国、加拿大和澳大利亚等主要国家，同时在印度孟买设有卓越中心，并建立了全球分销和商业化的合作伙伴网络。

ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, biosimilars & specialty generics, and originator brands. Our products cover a broad range of therapeutic areas, including hepatology, rheumatology, gastroenterology, anti-infectives, critical care, endocrinology, oncology, CNS, and, more broadly, rare disease medicines.

ADVANZ PHARMA的产品组合和研发管线包括创新药物、生物类似药及特种仿制药，以及原创品牌药物。我们的产品覆盖广泛的治疗领域，包括肝病学、风湿病学、胃肠病学、抗感染药物、重症监护、内分泌学、肿瘤学、中枢神经系统疾病，以及更广泛的罕见病药物。

Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with biopharma and development companies to bring medicines to patients. We can only achieve this due to our dedicated and highly qualified employees, acting in line with our company values of entrepreneurship, speed, and integrity..

我们的目标是成为欧洲、加拿大和澳大利亚专科、医院和罕见病药物商业化的首选合作伙伴。为实现这一目标，我们正与生物制药和开发公司合作，将药物带给患者。我们之所以能够做到这一点，是因为我们拥有敬业且高度合格的员工，他们以符合我们公司创业精神、速度和诚信的价值观行事。

For more information, please visit our Website or LinkedIn.

有关更多信息，请访问我们的网站或领英。

For media inquiries, please contact:

媒体咨询请联系：

Courtney Baines

考特尼·贝恩斯

ADVANZ PHARMA

ADVANZ制药

Tel: +44 7776 516979 Email: courtney.baines@advanzpharma.com

电话：+44 7776 516979 邮箱：courtney.baines@advanzpharma.com

Source: advanzpharma.com

来源：advanzpharma.com